Study Evaluating How Patients With Acute Coronary Syndrome Are Managed During 2 Years After Discharge

The aim of this international study is to describe the short- and long-term (i.e. up to 2 years following the index event) antithrombotic management patterns (AMPs) in patients hospitalized for acute coronary syndromes (ST segment elevation myocardial infarction (STEMI), Non-ST-Segment Elevation Acute Coronary Syndrome (NSTE-ACS)), and to document the impact of AMPs in clinical outcomes, economic variables and quality of life in a 'real-life' setting and to compare these between sites, countries and regions.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

ACS Acute Coronary Syndrome Angina Pectoris Angina, Unstable Arterial Occlusive Diseases Arteriosclerosis Cardiovascular Diseases Chest Pain Coronary Artery Disease Coronary Disease Heart Diseases Infarction Ischemia Myocardial Infarction Myocardial Ischemia Necrosis Neurologic Manifestations Pain Pathologic Processes Pathological Conditions, Signs and Symptoms Signs and Symptoms Unstable Angina Vascular Diseases

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Research Site, Avellaneda, Argentina

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Diagnosis of myocardial infarction or unstable angina
Hospitalized for the first time within 24 hours of onset of symptoms

Exclusion criteria

Presence of any condition/circumstance which in the opinion of the investigator could significantly limit the complete follow up of the patient (e.g. tourist, non-native speaker or does not understand the local language, psychiatric disturbances)
Current participation in a clinical trial.

Treatment and study plan

Primary outcomes

Clinical outcomes (ischemic and bleeding) incidence and time to these clinical outcomes

Time frame: Longitudinal during 2 years after index event (phone calls to the patients at 6 weeks and each 3 months after index event)

Secondary outcomes

Antithrombotic treatments

Time frame: Longitudinal during 2 years after index event (phone calls to the patients at 6 weeks and each 3 months after index event)
Use of health care resources

Time frame: Longitudinal during 2 years after index event (phone calls to the patients at 6 weeks and each 3 months after index event)
Quality of life

Time frame: At index event (baseline) and then at 6 weeks and each 3 months after index event

Sponsors and collaborators

Lead sponsor

AstraZeneca

Industry

Registry information

Official study title

Long-term Follow-up of Antithrombotic Management Patterns in Acute Coronary Syndrome Patients

Acronym: EPICOR

Important dates

Study start: 2010
Primary completion: 2013
Study completion: 2013
First posted: Jul 28, 2010
Registry last updated: Apr 17, 2013

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed